U-Systems Inc., the Silicon Valley maker of a cancer test for women with dense breasts, said it’s seeking to partner with a larger medical-imaging company after winning U.S. regulatory approval for the ultrasound technology.
A company with a women’s health unit would help Sunnyvale, California-based U-Systems and its 35 employees sell the somo-v ABUS breast-cancer ultrasound, Chief Executive Officer Ron Ho said in a telephone interview. The device, approved by the Food and Drug Administration last week, is the first ultrasound for the 40 percent of women who have thick connective and glandular breast tissue that normal mammograms can’t properly distinguish.
Read the full story: bloom.bg/UNufco
Source: Bloomberg
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More